Everything You Need to Know About the FDA’s Proposed Benefit-Risk Assessment for New Drug and Biological Products

Posted by Chad Birt on Mar 4, 2022 10:00:00 AM

On September 29, 2021, The Food and Drug Administration (FDA), released a proposed benefit-risk assessment for new drug and biological products. The document, published in draft guidance form, shines a spotlight on the FDA’s decision-making processes. 

Read More

Topics: clinical trial, clinical trial strategic planning, clinical trial consulting, clinical trial remote services, fda, Clinical Research, Biotech, Pharmaceuticals, biotechnology, pharma, qualityassurance, biostatistics, biometrics, FSP, Functional Service Provider, clinical trials, project management, Good Clinical Practice, FDA inspections, supply chain, biopharma, biomedical research, medical research, supply chain management, medical device manufacturer, supply chain shortage, food and drug administration

Rare Disease Day 2022: How The Pharmaceutical Industry Has Stepped Up and Tips for Bringing Treatments to Market

Posted by Chad Birt on Jan 25, 2022 8:00:00 AM

Imagine being diagnosed with an incurable disease. Now, imagine being diagnosed with an incurable disease that affects less than 2,000 people globally. That’s the reality more than 300 million people are living worldwide. The reality of life with a rare disease.

Read More

Topics: clinical trial, clinical trial strategic planning, clinical trial consulting, clinical trial remote services, Clinical Research, Biotech, Pharmaceuticals, biotechnology, pharma, qualityassurance, biostatistics, biometrics, FSP, Functional Service Provider, clinical trials, project management, Good Clinical Practice, supply chain, biopharma, biomedical research, medical research, supply chain management, medical device manufacturer, supply chain shortage, rare disease awareness, rare diseases, genetic diseases

What Medical Device Manufacturers and Biopharmas Can Do to Reduce Supply Chain Headaches

Posted by Chad Birt on Dec 14, 2021 9:00:00 AM

For more than a year now, the global supply chain has experienced significant disruptions. At the beginning of the COVID-19 pandemic, factories manufacturing everyday objects like semiconductors, personal protective equipment, and bicycles, shut down resulting in global product shortages and long-lasting headaches for many business owners. 

Read More

Topics: clinical trial, clinical trial strategic planning, clinical trial consulting, clinical trial remote services, Clinical Research, Biotech, Pharmaceuticals, biotechnology, pharma, qualityassurance, biostatistics, biometrics, FSP, Functional Service Provider, clinical trials, project management, Good Clinical Practice, supply chain, biopharma, biomedical research, medical research, supply chain management, medical device manufacturer, supply chain shortage

Learn More From Us

We’re committed to quality and committed to meeting or exceeding your expectations.

Established to be your integrated Quality Assurance and Regulatory Compliance partner, with a laser focus on facilitating your clinical trial execution. Developing and supporting your quality initiatives from Day 1, the Harbor team is committed to quality through each functional service we provide.

We provide a hybrid of services which ensure all aspects of clinical trials meet quality assurance and regulatory standards – from study documentation, vendor oversight, and flexible resourcing throughout operations.

Watch our blog for articles that help you get the most from your clinical trials.

Subscribe Here!

Recent Posts

Posts by Tag

See all